(NASDAQ: BLLN) Billiontoone's forecast annual revenue growth rate of 22.67% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.69%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.9%.
Billiontoone's revenue in 2026 is $397,412,000.On average, 11 Wall Street analysts forecast BLLN's revenue for 2026 to be $21,926,400,947, with the lowest BLLN revenue forecast at $20,675,472,570, and the highest BLLN revenue forecast at $22,840,885,744. On average, 11 Wall Street analysts forecast BLLN's revenue for 2027 to be $27,678,972,750, with the lowest BLLN revenue forecast at $25,632,470,912, and the highest BLLN revenue forecast at $28,984,638,092.
In 2028, BLLN is forecast to generate $34,910,386,324 in revenue, with the lowest revenue forecast at $30,256,800,636 and the highest revenue forecast at $38,646,184,122.